An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior

Cell

Volumn 122, Issue 2, 2005, Pages 261-273

  Beaulieu, Jean Martin ^a   Sotnikova, Tatyana D ^a   Marion, Sébastien ^a   Lefkowitz, Robert J ^a   Gainetdinov, Raul R ^a   Caron, Marc G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; APOMORPHINE; BETA ARRESTIN; CYCLIC AMP; DOPAMINE; DOPAMINE 2 RECEPTOR; PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOTRANSFERASE; PROTEIN KINASE B; REGULATOR PROTEIN; SCAFFOLD PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; ENZYME REGULATION; LOCOMOTION; MALE; MENTAL DISEASE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN TARGETING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 22744449073     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2005.05.012     Document Type: Article

References (51)

1. S. Ahn, S.K. Shenoy, H. Wei, and R.J. Lefkowitz Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor J. Biol. Chem. 279 2004 35518 35525
2. D.R. Alessi, M. Andjelkovic, B. Caudwell, P. Cron, N. Morrice, P. Cohen, and B.A. Hemmings Mechanism of activation of protein kinase B by insulin and IGF-1 EMBO J. 15 1996 6541 6551
3. D.R. Alessi, S.R. James, C.P. Downes, A.B. Holmes, P.R. Gaffney, C.B. Reese, and P. Cohen Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha Curr. Biol. 7 1997 261 269
4. M. Andjelkovic, T. Jakubowicz, P. Cron, X.F. Ming, J.W. Han, and B.A. Hemmings Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors Proc. Natl. Acad. Sci. USA 93 1996 5699 5704
5. H. Attramadal, J.L. Arriza, C. Aoki, T.M. Dawson, J. Codina, M.M. Kwatra, S.H. Snyder, M.G. Caron, and R.J. Lefkowitz Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family J. Biol. Chem. 267 1992 17882 17890
6. J.M. Beaulieu, T.D. Sotnikova, W.D. Yao, L. Kockeritz, J.R. Woodgett, R.R. Gainetdinov, and M.G. Caron Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade Proc. Natl. Acad. Sci. USA 101 2004 5099 5104
7. L.M. Bohn, R.J. Lefkowitz, R.R. Gainetdinov, K. Peppel, M.G. Caron, and F.T. Lin Enhanced morphine analgesia in mice lacking beta-arrestin 2 Science 286 1999 2495 2498
8. L.M. Bohn, R.R. Gainetdinov, T.D. Sotnikova, I.O. Medvedev, R.J. Lefkowitz, L.A. Dykstra, and M.G. Caron Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice J. Neurosci. 23 2003 10265 10273
9. K. Brami-Cherrier, E. Valjent, M. Garcia, C. Pages, R.A. Hipskind, and J. Caboche Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons: a new route to cAMP response element-binding protein phosphorylation J. Neurosci. 22 2002 8911 8921
10. A. Carlsson A paradigm shift in brain research Science 294 2001 1021 1024
11. E. Chalecka-Franaszek, and D.M. Chuang Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons Proc. Natl. Acad. Sci. USA 96 1999 8745 8750
12. D.A. Cross, D.R. Alessi, P. Cohen, M. Andjelkovich, and B.A. Hemmings Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B Nature 378 1995 785 789
13. M. Cyr, J.M. Beaulieu, A. Laakso, T.D. Sotnikova, W.D. Yao, L.M. Bohn, R.R. Gainetdinov, and M.G. Caron Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons Proc. Natl. Acad. Sci. USA 100 2003 11035 11040
14. E.S. Emamian, D. Hall, M.J. Birnbaum, M. Karayiorgou, and J.A. Gogos Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia Nat. Genet. 36 2004 131 137
15. S.S. Ferguson, W.E. Downey 3rd, A.M. Colapietro, L.S. Barak, L. Menard, and M.G. Caron Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization Science 271 1996 363 366
16. A.A. Fienberg, N. Hiroi, P.G. Mermelstein, W. Song, G.L. Snyder, A. Nishi, A. Cheramy, J.P. O'Callaghan, D.B. Miller, and D.G. Cole DARPP-32: regulator of the efficacy of dopaminergic neurotransmission Science 281 1998 838 842
17. R.R. Gainetdinov, L.M. Bohn, T.D. Sotnikova, M. Cyr, A. Laakso, A.D. Macrae, G.E. Torres, K.M. Kim, R.J. Lefkowitz, M.G. Caron, and R.T. Premont Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice Neuron 38 2003 291 303
18. R.R. Gainetdinov, and M.G. Caron Monoamine transporters: from genes to behavior Annu. Rev. Pharmacol. Toxicol. 43 2003 261 284
19. R.R. Gainetdinov, W.C. Wetsel, S.R. Jones, E.D. Levin, M. Jaber, and M.G. Caron Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity Science 283 1999 397 401
20. R.R. Gainetdinov, R.T. Premont, L.M. Bohn, R.J. Lefkowitz, and M.G. Caron Desensitization of G protein-coupled receptors and neuronal functions Annu. Rev. Neurosci. 27 2004 107 144
21. B. Giros, M. Jaber, S.R. Jones, R.M. Wightman, and M.G. Caron Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter Nature 379 1996 606 612
22. R. Goel, P.J. Phillips-Mason, D.M. Raben, and J.J. Baldassare alpha-Thrombin induces rapid and sustained Akt phosphorylation by beta-arrestin1-dependent and -independent mechanisms, and only the sustained Akt phosphorylation is essential for G1 phase progression J. Biol. Chem. 277 2002 18640 18648
23. T.D. Gould, H. Einat, R. Bhat, and H.K. Manji AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test Int. J. Neuropsychopharmacol. 7 2004 387 390
24. P. Greengard The neurobiology of slow synaptic transmission Science 294 2001 1024 1030
25. M. Ikeda, N. Iwata, T. Suzuki, T. Kitajima, Y. Yamanouchi, Y. Kinoshita, T. Inada, and N. Ozaki Association of AKT1 with schizophrenia confirmed in a Japanese population Biol. Psychiatry 56 2004 698 700
26. V. Janssens, and J. Goris Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling Biochem. J. 353 2001 417 439
27. T.M. Jessell, and E.R. Kandel Synaptic transmission: a bidirectional and self-modifiable form of cell-cell communication Cell 72 Suppl. 1993 S1 S30
28. S.R. Jones, R.R. Gainetdinov, M. Jaber, B. Giros, R.M. Wightman, and M.G. Caron Profound neuronal plasticity in response to inactivation of the dopamine transporter Proc. Natl. Acad. Sci. USA 95 1998 4029 4034
29. U.G. Kang, M.S. Seo, M.S. Roh, Y. Kim, S.C. Yoon, and Y.S. Kim The effects of clozapine on the GSK-3-mediated signaling pathway FEBS Lett. 560 2004 115 119
30. J.G. Krupnick, O.B. Goodman Jr., J.H. Keen, and J.L. Benovic Arrestin/clathrin interaction. Localization of the clathrin binding domain of nonvisual arrestins to the carboxy terminus J. Biol. Chem. 272 1997 15011 15016
31. R.J. Lefkowitz, and S.K. Shenoy Transduction of receptor signals by beta-arrestins Science 308 2005 512 517
32. L. Li, C.H. Ren, S.A. Tahir, C. Ren, and T.C. Thompson Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A Mol. Cell. Biol. 23 2003 9389 9404
33. L.M. Luttrell, S.S. Ferguson, Y. Daaka, W.E. Miller, S. Maudsley, G.J. Della Rocca, F. Lin, H. Kawakatsu, K. Owada, and D.K. Luttrell Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes Science 283 1999 655 661
34. L.M. Luttrell, F.L. Roudabush, E.W. Choy, W.E. Miller, M.E. Field, K.L. Pierce, and R.J. Lefkowitz Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds Proc. Natl. Acad. Sci. USA 98 2001 2449 2454
35. A. McCluskey, and J.A. Sakoff Small molecule inhibitors of serine/threonine protein phosphatases Mini Rev. Med. Chem. 1 2001 43 55
36. T.A. Millward, S. Zolnierowicz, and B.A. Hemmings Regulation of protein kinase cascades by protein phosphatase 2A Trends Biochem. Sci. 24 1999 186 191
37. C. Missale, S.R. Nash, S.W. Robinson, M. Jaber, and M.G. Caron Dopamine receptors: from structure to function Physiol. Rev. 78 1998 189 225
38. V.D. Nair, and S.C. Sealfon Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor J. Biol. Chem. 278 2003 47053 47061
39. R.E. Nally, F.N. McNamara, J.J. Clifford, A. Kinsella, O. Tighe, D.T. Croke, A.A. Fienberg, P. Greengard, and J.L. Waddington Topographical Assessment of Ethological and Dopamine Receptor Agonist-Induced Behavioral Phenotype in Mutants with Congenic DARPP-32 'Knockout.' Neuropsychopharmacology 28 2003 2055 2063
40. A. Nishi, G.L. Snyder, and P. Greengard Bidirectional regulation of DARPP-32 phosphorylation by dopamine J. Neurosci. 17 1997 8147 8155
41. T.J. Povsic, T.A. Kohout, and R.J. Lefkowitz Beta-arrestin1 mediates insulin-like growth factor 1 (IGF-1) activation of phosphatidylinositol 3-kinase (PI3K) and anti-apoptosis J. Biol. Chem. 278 2003 51334 51339
42. M.P. Scheid, and J.R. Woodgett PKB/AKT: functional insights from genetic models Nat. Rev. Mol. Cell Biol. 2 2001 760 768
43. S.H. Snyder The dopamine hypothesis of schizophrenia: focus on the dopamine receptor Am. J. Psychiatry 133 1976 197 202
44. S. Ugi, T. Imamura, H. Maegawa, K. Egawa, T. Yoshizaki, K. Shi, T. Obata, Y. Ebina, A. Kashiwagi, and J.M. Olefsky Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes Mol. Cell. Biol. 24 2004 8778 8789
45. N. Unwin Neurotransmitter action: opening of ligand-gated ion channels Cell 72 Suppl. 1993 S31 S41
46. E. Valjent, J.C. Corvol, C. Pages, M.J. Besson, R. Maldonado, and J. Caboche Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties J. Neurosci. 20 2000 8701 8709
47. D.K. Vassilatis, J.G. Hohmann, H. Zeng, F. Li, J.E. Ranchalis, M.T. Mortrud, A. Brown, S.S. Rodriguez, J.R. Weller, and A.C. Wright The G protein-coupled receptor repertoires of human and mouse Proc. Natl. Acad. Sci. USA 100 2003 4903 4908
48. A.H. Walsh, A. Cheng, and R.E. Honkanen Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A FEBS Lett. 416 1997 230 234
49. Y.M. Wang, R.R. Gainetdinov, F. Fumagalli, F. Xu, S.R. Jones, C.B. Bock, G.W. Miller, R.M. Wightman, and M.G. Caron Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine Neuron 19 1997 1285 1296
50. R.E. Wilcox, R.V. Smith, J.A. Anderson, and W.H. Riffee Apomorphine-induced stereotypic cage climbing in mice as a model for studying changes in dopamine receptor sensitivity Pharmacol. Biochem. Behav. 12 1980 29 33
51. Q.Y. Zhou, and R.D. Palmiter Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic Cell 83 1995 1197 1209